Northwestern filed a lawsuit against Moderna Wednesday alleging the company misused the University’s patented lipid ...

The discovery of the first mRNA-stabilizing substance could pave the way for groundbreaking advancements in the development ...

By Tarun Sai Lomte Groundbreaking study reveals new single-chain mRNA vaccines provide 100% protection against lethal mpox ...

On Monday, Moderna Inc (MRNA) stock saw a decline, ending the day at $53.8 which represents a decrease of $-0.30 or -0.55% from the prior close of $54.1. The stock opened at $53.82 and touched a low ...

At IDWeek 2024, Moderna presented interim results from an ongoing Phase I/II dose-ranging trial for mRNA-1403, a vaccine ...

Hello Health Rounds Readers! Today we report on a promising animal study of a mRNA vaccine that could one day prevent or ...

In an era where viral outbreaks can escalate into global pandemics with alarming speed, the ability to quickly develop new ...

A single COVID-19 mRNA vaccine dose provided similar protection to that conferred by a 2-dose series among immunocompetent ...

Discover why the stock prices of mRNA therapy creators BioNTech and Moderna have plummeted and whether they are still worth ...

A British drugmaker, GlaxoSmithKline (GSK), has sued American pharmaceutical company Moderna claiming it violated patent ...

Revaccination at 12 months with the investigational respiratory syncytial virus (RSV) vaccine mRNA-1345 is well tolerated and supported for eligible older adults, according to study results presented ...

CAMBRIDGE, Mass. and VANCOUVER, British Columbia and BASEL, Switzerland, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: ...